BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Tumor necrosis factor-inducible gene 6 interacts with CD44, which is involved in fate-change of hepatic stellate cells

  • Wang, Sihyung (Department of Integrated Biological Science, Pusan National University) ;
  • Kim, Jieun (Department of Integrated Biological Science, Pusan National University) ;
  • Lee, Chanbin (Department of Integrated Biological Science, Pusan National University) ;
  • Jung, Youngmi (Department of Integrated Biological Science, Pusan National University)
  • Received : 2019.11.05
  • Accepted : 2020.02.21
  • Published : 2020.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Tumor necrosis factor-inducible gene 6 protein (TSG-6) is a cytokine secreted by mesenchymal stem cells (MSCs) and regulates MSC stemness. We previously reported that TSG-6 changes primary human hepatic stellate cells (pHSCs) into stem-like cells by activating yes-associated protein-1 (YAP-1). However, the molecular mechanism behind the reprogramming action of TSG-6 in pHSCs remains unknown. Cluster of differentiation 44 (CD44) is a transmembrane protein that has multiple functions depending on the ligand it is binding, and it is involved in various signaling pathways, including the Wnt/β-catenin pathway. Given that β-catenin influences stemness and acts downstream of CD44, we hypothesized that TSG-6 interacts with the CD44 receptor and stimulates β-catenin to activate YAP-1 during TSG-6-mediated transdifferentiation of HSCs. Immunoprecipitation assays showed the interaction of TSG-6 with CD44, and immunofluorescence staining analyses revealed the colocalization of TSG-6 and CD44 at the plasma membrane of TSG-6-treated pHSCs. In addition, TSG-6 treatment upregulated the inactive form of phosphorylated glycogen synthase kinase (GSK)-3β, which is a negative regulator of β-catenin, and promoted nuclear accumulation of active/nonphosphorylated β-catenin, eventually leading to the activation of YAP-1. However, CD44 suppression in pHSCs following CD44 siRNA treatment blocked the activation of β-catenin and YAP-1, which inhibited the transition of TSG-6-treated HSCs into stem-like cells. Therefore, these findings demonstrate that TSG-6 interacts with CD44 and activates β-catenin and YAP-1 during the conversion of TSG-6-treated pHSCs into stem-like cells, suggesting that this novel pathway is an effective therapeutic target for controlling liver disease.

Keywords

References

  1. Carelli S, Colli M, Vinci V, Caviggioli F, Klinger M and Gorio A (2018) Mechanical Activation of Adipose Tissue and Derived Mesenchymal Stem Cells: Novel Anti-Inflammatory Properties. Int J Mol Sci 19, pii: E267
  2. Romano B, Elangovan S, Erreni M et al (2019) TNF-Stimulated Gene-6 Is a Key Regulator in Switching Stemness and Biological Properties of Mesenchymal Stem Cells. Stem Cells 37, 973-987 https://doi.org/10.1002/stem.3010
  3. Wang S, Kim J, Lee C et al (2019) Tumor necrosis factorinducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse. Biomaterials 219, 119375 https://doi.org/10.1016/j.biomaterials.2019.119375
  4. Cao H, Heazlewood SY, Williams B et al (2016) The role of CD44 in fetal and adult hematopoietic stem cell regulation. Haematologica 101, 26-37 https://doi.org/10.3324/haematol.2015.135921
  5. Baaten BJ, Li CR and Bradley LM (2010) Multifaceted regulation of T cells by CD44. Commun Integr Biol 3, 508-512 https://doi.org/10.4161/cib.3.6.13495
  6. Johnson P and Ruffell B (2009) CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 8, 208-220 https://doi.org/10.2174/187152809788680994
  7. van der Windt GJ, Florquin S, de Vos AF et al (2010) CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during Gramnegative pneumonia. Am J Pathol 177, 2483-2494 https://doi.org/10.2353/ajpath.2010.100562
  8. Thapa R and Wilson GD (2016) The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer. Stem Cells Int 2016, 2087204
  9. Du L, Wang H, He L et al (2008) CD44 is of Functional Importance for Colorectal Cancer Stem Cells. Clin Cancer Res 14, 6751-6760 https://doi.org/10.1158/1078-0432.CCR-08-1034
  10. Zhu H, Mitsuhashi N, Klein A et al (2006) The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24, 928-935 https://doi.org/10.1634/stemcells.2005-0186
  11. Lesley J, Hyman R and Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54, 271-335 https://doi.org/10.1016/S0065-2776(08)60537-4
  12. Bourguignon LY (2008) Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol 18, 251-259 https://doi.org/10.1016/j.semcancer.2008.03.007
  13. Orian-Rousseau V, Morrison H, Matzke A et al (2007) Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Mol Biol Cell 18, 76-83 https://doi.org/10.1091/mbc.E06-08-0674
  14. Herishanu Y, Gibellini F, Njuguna N et al (2011) Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1. Leuk Lymphoma 52, 1758-1769 https://doi.org/10.3109/10428194.2011.569962
  15. Schmitt M, Metzger M, Gradl D, Davidson G and Orian-Rousseau V (2015) CD44 functions in Wnt signaling by regulating LRP6 localization and activation. Cell Death Differ 22, 677-689 https://doi.org/10.1038/cdd.2014.156
  16. Choi H, Lee RH, Bazhanov N, Oh JY and Prockop DJ (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 118, 330-338 https://doi.org/10.1182/blood.v118.21.330.330
  17. Zhan T, Rindtorff N and Boutros M (2017) Wnt signaling in cancer. Oncogene 36, 1461-1473 https://doi.org/10.1038/onc.2016.304
  18. Steinhart Z and Angers S (2018) Wnt signaling in development and tissue homeostasis. Development 145, pii: dev146589
  19. Shi J, Zheng H and Yuan L (2019) High NDRG3 Expression Facilitates HCC Metastasis by Promoting Nuclear Translocation of ${\beta}$-Catenin. BMB Rep 52, 451-456 https://doi.org/10.5483/bmbrep.2019.52.7.201
  20. Behrens J, Jerchow BA, Wurtele M et al (1998) Functional Interaction of an Axin Homolog, Conductin, with ${\beta}$-Catenin, APC, and $GSK3{\beta}$. Science 280, 596-599 https://doi.org/10.1126/science.280.5363.596
  21. He TC, Sparks AB, Rago C et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 https://doi.org/10.1126/science.281.5382.1509
  22. Bottomly D, Kyler SL, McWeeney SK and Yochum GS (2010) Identification of ${\beta}$-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res 38, 5735-5745 https://doi.org/10.1093/nar/gkq363
  23. Konsavage WM Jr, Kyler SL, Rennoll SA, Jin G and Yochum GS (2012) Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem 287, 11730-11739 https://doi.org/10.1074/jbc.M111.327767
  24. Miki T, Yasuda SY and Kahn M (2011) Wnt/beta-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming. Stem Cell Rev Rep 7, 836-846 https://doi.org/10.1007/s12015-011-9275-1
  25. Chang G, Zhang H, Wang J et al (2013) CD44 targets Wnt/beta-catenin pathway to mediate the proliferation of K562 cells. Cancer Cell Int 13, 117 https://doi.org/10.1186/1475-2867-13-117
  26. Zhu X, Morales FC, Agarwal NK, Dogruluk T, Gagea M and Georgescu MM (2013) Moesin is a glioma progression marker that induces proliferation and Wnt/betacatenin pathway activation via interaction with CD44. Cancer Res 73, 1142-1155 https://doi.org/10.1158/0008-5472.CAN-12-1040
  27. Yovchev MI, Grozdanov PN, Joseph B, Gupta S and Dabeva MD (2007) Novel hepatic progenitor cell surface markers in the adult rat liver. Hepatology 45, 139-149 https://doi.org/10.1002/hep.21448
  28. Satoh T, Ichida T, Matsuda Y et al (2000) Interaction between hyaluronan and CD44 in the development of dimethylnitrosamine-induced liver cirrhosis. J Gastroenterol Hepatol 15, 402-411 https://doi.org/10.1046/j.1440-1746.2000.02164.x
  29. Kikuchi S, Griffin CT, Wang SS and Bissell DM (2005) Role of CD44 in epithelial wound repair: migration of rat hepatic stellate cells utilizes hyaluronic acid and CD44v6. J Biol Chem 280, 15398-15404 https://doi.org/10.1074/jbc.M414048200
  30. Chen C, Zhao S, Karnad A and Freeman JW (2018) The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol 11, 64 https://doi.org/10.1186/s13045-018-0605-5
  31. Lesley J, English NM, Gal I, Mikecz K, Day AJ and Hyman R (2002) Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6. J Biol Chem 277, 26600-26608 https://doi.org/10.1074/jbc.M201068200
  32. Lesley J, Gal I, Mahoney DJ et al (2004) TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J Biol Chem 279, 25745-25754 https://doi.org/10.1074/jbc.M313319200